Name: UMIN ID:
Unique ID issued by UMIN | UMIN000021305 |
---|---|
Receipt number | R000023920 |
Scientific Title | Phase II clinical trial of Gemcitabine and Nab-Pacritaxel combined therapy for pancreatic cancer with the difficulty of curative resection |
Date of disclosure of the study information | 2016/03/07 |
Last modified on | 2016/03/31 14:54:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/03/03 07:44:01 | ||
2 | Update | 2016/03/07 19:01:29 | Date of disclosure of the study information |
|
3 | Update | 2016/03/07 19:12:35 | Research ethics review |
|
4 | Update | 2016/03/31 14:54:18 | Research ethics review |
|
5 | Update | 2016/03/31 14:54:46 | Recruitment status |